A 68-year-old man from Delhi presents with progressive lower urinary tract symptoms for 8 months. He reports nocturia 4–5 times per night, hesitancy, weak urinary stream, and incomplete emptying. On examination, his prostate is smooth, firm, and symmetrically enlarged (grade II). Post-void residual (PVR) by ultrasound is 85 mL. Serum creatinine is 1.2 mg/dL. Urinalysis is normal. He is keen to avoid surgery. Which of the following is the most appropriate initial pharmacological management?

Explanation

## Clinical Context This patient presents with moderate lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) with evidence of obstruction (weak stream, hesitancy, PVR 85 mL). He desires medical management. ## Pharmacological Options in BPH | Drug Class | Mechanism | Onset | Symptom Relief | Best For | |---|---|---|---|---| | **α1-Blockers** (tamsulosin, doxazosin, alfuzosin) | Relax smooth muscle in prostatic urethra | 1–2 weeks | Rapid (LUTS) | Moderate–severe LUTS, rapid symptom relief | | **5α-Reductase Inhibitors** (finasteride, dutasteride) | Reduce DHT, shrink prostate | 3–6 months | Slow (gland size) | Large prostate (>40 g), long-term prevention | | **Combination** | Both mechanisms | Variable | Additive | Severe LUTS + large prostate | ## Why Tamsulosin 0.4 mg Daily? **Key Point:** For moderate LUTS without severe obstruction or large prostate, α1-blockers are first-line because they provide rapid symptom relief within 1–2 weeks. **High-Yield:** Tamsulosin is preferred over non-selective α1-blockers (doxazosin, alfuzosin) because it is uroselective (acts preferentially on α1A receptors in the prostate) and has fewer systemic side effects (hypotension, dizziness). **Clinical Pearl:** PVR of 85 mL is moderate obstruction but not severe (severe is typically >150 mL). The patient's creatinine is normal, indicating no upper urinary tract compromise. This supports medical management without urgent intervention. ## When to Add a 5α-Reductase Inhibitor? **Key Point:** Finasteride is added if: - Prostate volume >40 g (not stated here), - Recurrent hematuria from BPH, - PSA >1.5 ng/mL with large gland (to reduce risk of acute retention and need for surgery). Since this patient has a grade II (moderate) prostate and no mention of large size, monotherapy with tamsulosin is appropriate initially.